Month

November 2020
Net income for the three-month period ending September 30th, 2020 increased to $8,890,748 and earnings per share increased to $0.12Net income for the nine-month period ending September 30th, 2020 increased to $13,617,124 and earnings per share increased to $0.18VST ended the quarter with a healthy balance sheet and closed an oversubscribed Brokered Private Placement of...
Read More
Molkom has over 24 years of experience representing pharmaceutical companies in Brazil and over 14 years in Latin America.  The company boasts over 45,000 professional contacts worldwide, 5500 plus direct access to buyers and sales and development contracts totaling over $250,000,000 CAD.* Molkom has ability and capacity to grow current sales and distribution networks for...
Read More
Victory Square Health’s Leishmaniasis Rapid Test received Brazilian MAPA approval for sale and usage in Brazil and  export to Mercosur Countries in Central and South America  ⑩ Leishmaniasis is a parasitic disease that affects humans and canines in Southern Europe, Central America, South America,  Mexico and the Middle East  ⑩ About 4 to 12 million...
Read More
Victory Square Health has entered into a new sales & distribution agreement with ProNorth Medical Corporation to provide its Safetest 15 minute Covid-19 Rapid Testing kits in the United States of America and in Canada* following Health Canada approvals. ProNorth Medical currently has multi-million dollar PPE products sales and distribution contracts with government, hospitals, and...
Read More
Victory Square Technologies Announces Closing of Upsized and Oversubscribed $6.1 Million Private Placement of Special Warrants Led by Gravitas Securities VANCOUVER, November 9, 2020 (GLOBE NEWSWIRE) – Victory Square Technologies Inc. (“Victory Square” or the “Company”) (CSE: VST) (OTC: VSQTF) (FWB: 6F6) is pleased to announce that it has completed its previously announced upsized and...
Read More